Excellergy

Palo Alto, California, United States · Biotechnology, Health Care · 7 employees

Excellergy is a biotechnology company developing a novel class of allergy therapeutics called Effector Cell Response Inhibitors (ECRIs). These agents aim to redefine allergy treatment by providing complete control of allergic responses through innovative mechanisms targeting effector cells. The company leverages scientific advancements to create a new therapeutic category designed to improve the l

See plans & pricing → Track Excellergy’s funding, hiring, and signals — with verified contacts — on Fundz.